Clinical Trials Directory

Trials / Completed

CompletedNCT05019651

Acceptability and Feasibility of Apollo in Veterans With a History of PTSD

Acceptability and Feasibility of Apollo Wearable System, Tuned Vibroacoustic Stimulation (TVS) in Veterans With a History of Post-traumatic Stress Disorder (PTSD)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Lisa Brenner · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The proposed investigation is an open label pilot study intended to establish the acceptability and feasibility of the Apollo in a population of Veterans. Exploratory data regarding biological signatures will also be collected.

Detailed description

Evaluation of Apollo requires a stepwise process in which initial aims are geared towards identifying biological signatures versus diagnosing, treating, mitigating or curing any conditions. Towards the end of identifying potential biological signatures, we hypothesize the following. 1) Participants who use the Apollo will have an attenuated physiological stress response as measured by improved heart rate variability (HRV) compared to baseline. 2) Participants who use Apollo will have attenuated perceived psychological stress measured by lower scores on psychological correlates of acute stress when compared to baseline

Conditions

Interventions

TypeNameDescription
DEVICEApollo Wearable SystemParticipants will be provided with the Apollo wearable device and asked to install the study mobile application on their mobile phone. Participants will use the Apollo for at least 30 minutes after waking up in the morning and at least 30 minutes before bed on the corresponding settings for those times of day. They will be given the Apollo Device TVS (10-200 Hz) to borrow which they will be instructed to wear for 6 +/- 2 weeks. They will be asked to continue to wear the device until all study data is collected.

Timeline

Start date
2022-02-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2021-08-25
Last updated
2025-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05019651. Inclusion in this directory is not an endorsement.